Skip to main content
Top
Published in:

Open Access 01-12-2024 | Thyroid Cancer | Case report

Spontaneous hepatic hemorrhage as presentation of metastasized papillary thyroid carcinoma: a case report

Authors: Jacob Thomasson, Bodil Andersson, Lo Hallin Thompson, Caroline Williamsson

Published in: Journal of Medical Case Reports | Issue 1/2024

Login to get access

Abstract

Background

Spontaneous hepatic hemorrhage is a rare condition, most commonly diagnosed in patients with hepatocellular carcinoma or hepatic adenomas, and is seldom caused by metastatic disease. In this case report, we present a patient with spontaneous hepatic hemorrhage due to hepatic metastasis of papillary thyroid carcinoma, an exceptionally rare occurrence.

Case presentation

The patient was a 77-year-old white male with a history of atrial fibrillation treated with apixaban. He presented at a local hospital with abdominal pain and nausea. A CT scan revealed a hepatic lesion in segment 3 with an adjacent hematoma. He was referred to our tertiary center and treated conservatively. Further evaluation revealed an intrathoracic goiter containing a tumorous process diagnosed as a papillary thyroid carcinoma (PTC), and the patient subsequently underwent thyroidectomy. A biopsy of the hepatic lesion confirmed it as a PTC metastasis. Due to worsening abdominal pain and anorexia, the patient underwent subacute hepatic segmental resection. Postoperatively, he developed iodine-refractory disease with disseminated metastasis and passed away 22 months after the initial admission.

Conclusions

To our knowledge, this is the first recorded case of metastasized papillary thyroid carcinoma presenting with spontaneous hepatic hemorrhage—adding to the list of rare causes for this condition.
Literature
1.
go back to reference Battula N, Tsapralis D, Takhar A, Coldham C, Mayer D, Isaac J, et al. Aetio-pathogenesis and the management of spontaneous liver bleeding in the West: a 16-year single-centre experience. HPB. 2012;14(6):382–9.CrossRefPubMedPubMedCentral Battula N, Tsapralis D, Takhar A, Coldham C, Mayer D, Isaac J, et al. Aetio-pathogenesis and the management of spontaneous liver bleeding in the West: a 16-year single-centre experience. HPB. 2012;14(6):382–9.CrossRefPubMedPubMedCentral
2.
go back to reference Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, et al. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022;1(161):108–18.CrossRef Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, et al. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022;1(161):108–18.CrossRef
3.
4.
go back to reference Darnis B, Rode A, Mohkam K, Ducerf C, Mabrut JY. Management of bleeding liver tumors. J Visc Surg. 2014;151:365–75.CrossRefPubMed Darnis B, Rode A, Mohkam K, Ducerf C, Mabrut JY. Management of bleeding liver tumors. J Visc Surg. 2014;151:365–75.CrossRefPubMed
5.
go back to reference Sahu SK, Chawla YK, Dhiman RK, Singh V, Duseja A, Taneja S, et al. Rupture of hepatocellular carcinoma: a review of literature. J Clin Exp Hepatol. 2019;9:245–56.CrossRefPubMed Sahu SK, Chawla YK, Dhiman RK, Singh V, Duseja A, Taneja S, et al. Rupture of hepatocellular carcinoma: a review of literature. J Clin Exp Hepatol. 2019;9:245–56.CrossRefPubMed
6.
go back to reference Nykänen T, Peltola E, Sallinen V, Mäkisalo H, Nordin A, Kylänpää L, et al. Transcatheter arterial embolization in hepatic tumor hemorrhage. Scand J Gastroenterol. 2019;54(7):917–24.CrossRefPubMed Nykänen T, Peltola E, Sallinen V, Mäkisalo H, Nordin A, Kylänpää L, et al. Transcatheter arterial embolization in hepatic tumor hemorrhage. Scand J Gastroenterol. 2019;54(7):917–24.CrossRefPubMed
7.
go back to reference Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.CrossRefPubMedPubMedCentral Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.CrossRefPubMedPubMedCentral
8.
go back to reference Ostrovsky V, Bar-Zakai B, Miller R, Schiller T, Kirzhner A, Knobler H, et al. Single liver metastasis of a follicular variant of papillary thyroid carcinoma: a rare pattern of organ spread. Endocrinol Diabetes Metab Case Rep. 2020;2020(1):1–5. Ostrovsky V, Bar-Zakai B, Miller R, Schiller T, Kirzhner A, Knobler H, et al. Single liver metastasis of a follicular variant of papillary thyroid carcinoma: a rare pattern of organ spread. Endocrinol Diabetes Metab Case Rep. 2020;2020(1):1–5.
9.
go back to reference Madani A, Jozaghi Y, Tabah R, How J, Mitmaker E. Rare metastases of well-differentiated thyroid cancers: a systematic review. Ann Surg Oncol. 2015;22(2):460–6.CrossRefPubMed Madani A, Jozaghi Y, Tabah R, How J, Mitmaker E. Rare metastases of well-differentiated thyroid cancers: a systematic review. Ann Surg Oncol. 2015;22(2):460–6.CrossRefPubMed
10.
go back to reference Mitchell AL, Gandhi A, Scott-Coombes D, Perros P. Management of thyroid cancer: United Kingdom National multidisciplinary guidelines. J Laryngol Otol. 2016;130(S2):S150–60.CrossRefPubMedPubMedCentral Mitchell AL, Gandhi A, Scott-Coombes D, Perros P. Management of thyroid cancer: United Kingdom National multidisciplinary guidelines. J Laryngol Otol. 2016;130(S2):S150–60.CrossRefPubMedPubMedCentral
11.
go back to reference Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J. 2017;6:225–37.CrossRefPubMedPubMedCentral Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J. 2017;6:225–37.CrossRefPubMedPubMedCentral
12.
go back to reference Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341–6.CrossRefPubMed Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341–6.CrossRefPubMed
13.
go back to reference Benbassat CA, Mechlis-Frish S, Hirsch D. Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer. World J Surg. 2006;30:1088–95.CrossRefPubMed Benbassat CA, Mechlis-Frish S, Hirsch D. Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer. World J Surg. 2006;30:1088–95.CrossRefPubMed
14.
go back to reference Xu J, Hong J, Wang Y, Zhou L, Xu B, Si Y, et al. Prognostic influence of spontaneous tumor rupture in patients with hepatocellular carcinoma after hepatectomy: a meta-analysis of observational studies. Front Surg. 2021;8:769233.CrossRefPubMedPubMedCentral Xu J, Hong J, Wang Y, Zhou L, Xu B, Si Y, et al. Prognostic influence of spontaneous tumor rupture in patients with hepatocellular carcinoma after hepatectomy: a meta-analysis of observational studies. Front Surg. 2021;8:769233.CrossRefPubMedPubMedCentral
Metadata
Title
Spontaneous hepatic hemorrhage as presentation of metastasized papillary thyroid carcinoma: a case report
Authors
Jacob Thomasson
Bodil Andersson
Lo Hallin Thompson
Caroline Williamsson
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2024
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-024-04797-5

Other articles of this Issue 1/2024

Journal of Medical Case Reports 1/2024 Go to the issue

2024 ESMO Congress

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

  • Webinar | 01-10-2024 | 12:30 (CEST)

Live event concluded

In this webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Get a reminder for the on-demand version